Advertisement

Topics

YM BioSciences Inc Company Profile

13:49 EDT 20th March 2019 | BioPortfolio

YM BioSciences Inc. is an oncology company that identifies, develops and commercializes differentiated products for patients worldwide. The Company is advancing two late-stage products: nimotuzumab, a humanized monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is approved in several countries for treatment of various types of head and neck cancer; and AeroLEF™, a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl in development for the treatment of moderate to severe pain, including cancer pain.

Location

5045 Orbitor Drive
Building 11, Suite 400
Mississauga
Ontario
L4W 4Y4
Canada

Contact

Phone: 905.629.9761
Fax: 905.629.4959
Email: ir@ymbiosciences.com


News Articles [622 Associated News Articles listed on BioPortfolio]

Illumina to Acquire Pacific Biosciences for Approximately $1.2 Billion

Illumina, Inc. and Pacific Biosciences announced they have signed an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in an all-cash transaction....

AUM Biosciences looks to advance anti-cancer molecule to Phase 2 later this year

AUM Biosciences CEO Vishal Doshi sat down with Proactive Investors at the BIO CEO and Investor Conference in New York. AUM Biosciences is a Singapore-based oncology-focused biotech company.

Life Biosciences LLC leads strategic investment in Prana

(Life Biosciences) Prana Biotechnology Ltd (ASX: PBT, NASDAQ: PRAN) ('Prana' or 'the Company') has today announced that it has entered into a securities purchase agreement for a lead investment by Bos...

Illumina To Acquire Pacific Biosciences At $8.00/shr

SAN DIEGO (dpa-AFX) - Illumina, Inc. (ILMN) and Pacific Biosciences (PACB) announced an agreement for Illumina to acquire Pacific Biosciences at a price of $8.00 per Pacific Biosciences share in a...

Caladrius Biosciences, Inc.: Caladrius Biosciences announces Purchase Agreement with Lincoln Park Capital for up to $26 million

BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ('Caladrius' or the 'Company'), a late-stage therapeutics development biopharmaceutical company committe...

Caladrius Biosciences, Inc.: Caladrius Biosciences Reports 2018 Fourth Quarter and Year End Financial Results

Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, NJ / ACCESSWIRE / March 14, 2019 / Caladrius Biosciences, Inc. (NASDAQ: CLBS) ("Caladrius" or the "Company"), a late-stage ther...

Tosoh Boosts Biosciences with Semba Buy

Japan’s Tosoh has strengthened and expanded its bioscience business following the acquisition of a 33.3% stake in Semba Biosciences. Financial details were not disclosed. Headquartered in Madiso...

Kuros Biosciences Ltd.: Kuros Biosciences appoints Strategic Advisory Board

Kuros Biosciences appoints Strategic Advisory Board Schlieren (Zurich), Switzerland, September 25, 2018 - Kuros Biosciences (SIX: KURN) today announced the formation of its Strategic Advisory Boar...

Drugs and Medications [33 Associated Drugs and Medications listed on BioPortfolio]

Eptifibatide [amneal biosciences]

These highlights do not include all the information needed to use EPTIFIBATIDE INJECTION safely and effectively. See full prescribing information for EPTIFIBATIDE INJECTION . EPTIFIBATIDE injection,...

Natelle one [meda pharmaceuticals]

natelleONE

Isoproterenol hydrochloride [amneal biosciences llc]

Isoproterenol Hydrochloride Injection, USP Rx only Sterile Injection

Spherusol [nielsen biosciences, inc.]

These highlights do not include all the information needed to use Spherusol safely and effectively. See full prescribing information for Spherusol . Coccidioides immitis Spherule-Derived Skin Test Ant...

Natelle one [azur pharma, inc.]

Natelle®OneRx Prenatal Vitamin & Plant-Based DHA

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Rheumatoid Arthritis

Hope Biosciences is conducting a research study of an investigational product called autologous adipose-derived mesenchymal stem cells (abbreviated as HB-adMSCs) as a possible treatment fo...

HepaStem Long-Term Safety Registry

All patients having received at least one infusion of the Investigational Medicinal Product (IMP) HepaStem HHALPC during a previous interventional clinical study conducted by Promethera Bi...

Treatment of Alveolar Bone Defects Using Aastrom Biosciences Autologous Tissue Repair Cell Therapy

The purpose of this research is to determine if a subject's own bone marrow tissue can help regenerate bone in the area of his/her jaw where a tooth has been removed using Tissue Repair Ce...

Identification of Predictive Factors for Survival of Patients With Recurrent Prostate Cancer From Clinical Features, Tissue Image Features and Molecular Biomarker Data

We seek to improve the predictive accuracy of the nomogram to predict survival for patients with castrate mets disease through the addition of pathological data, the results of automated m...

Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

Venn Biosciences Corporation ("InterVenn") has developed a liquid biopsy that is capable of distinguishing benign from malignant masses in women presenting with adnexal (pelvic) masses, th...

Companies [378 Associated Companies listed on BioPortfolio]

Hydra Biosciences, Inc.

Hydra Biosciences is a privately-held biopharmaceutical company based in Cambridge, Massachusetts, and develops drugs to treat pain, inflammation, anxiety and other diseases using...

Leadiant Biosciences, Inc.

Leadiant Biosciences, Inc. (formerly Sigma-Tau Pharmaceuticals, Inc.) is a U.S.-based, wholly owned subsidiary of Leadiant Biosciences S.p.A., a research-based pharmaceutical comp...

JeNu Biosciences

JeNu Biosciences was founded in 2008 by a team of ultrasound scientists, medical doctors and beauty executives and is currently led by Wayne Wager, CEO. JeNu Biosciences is a Seat...

DaVinci Biosciences LLC

DaVinci Biosciences LLC is a privately held company dedicated to advancing therapies that improve the quality of life for individuals suffering from trauma, disease and degenerative disorders. Through...

Ark Biosciences

Ark Biosciences is a privately held, clinical-stage global biotechnology company with its corporate office located in ZhangJiang Hi-Tech Park in Shanghai, its R&D Center in Suzhou...

More Information about "YM BioSciences Inc" on BioPortfolio

We have published hundreds of YM BioSciences Inc news stories on BioPortfolio along with dozens of YM BioSciences Inc Clinical Trials and PubMed Articles about YM BioSciences Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of YM BioSciences Inc Companies in our database. You can also find out about relevant YM BioSciences Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record